The index was also weakly associated with good outcome in ER+ breast cancers by GOBO meta-analysis (Figure 8C), suggesting that ephrin pathway signaling might contribute to the tumor-suppressive effects of TGF-β in ER+ breast cancer. This evidence concerns the gene TGFB1 and breast carcinoma.